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Primer synthesis by a eukaryotic-like archaeal
primase is independent of its Fe-S cluster
Sandro Holzer1, Jiangyu Yan2, Mairi L. Kilkenny1, Stephen D. Bell 2,3 & Luca Pellegrini 1
DNA replication depends on primase, the specialised polymerase responsible for synthesis of
the RNA primers that are elongated by the replicative DNA polymerases. In eukaryotic and
archaeal replication, primase is a heterodimer of two subunits, PriS and PriL. Recently, a third
primase subunit named PriX was identiﬁed in the archaeon Sulfolobus solfataricus. PriX is
essential for primer synthesis and is structurally related to the Fe–S cluster domain of
eukaryotic PriL. Here we show that PriX contains a nucleotide-binding site required for primer
synthesis, and demonstrate equivalence of nucleotide-binding residues in PriX with eukar-
yotic PriL residues that are known to be important for primer synthesis. A primase chimera,
where PriX is fused to a truncated version of PriL lacking the Fe–S cluster domain retains wild-
type levels of primer synthesis. Our evidence shows that PriX has replaced PriL as the subunit
that endows primase with the unique ability to initiate nucleic acid synthesis. Importantly, our
ﬁndings reveal that the Fe–S cluster is not required for primer synthesis.
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Initiation of DNA synthesis during DNA replication relies on aspecialised DNA-dependent RNA polymerase, known as pri-mase. Primase possesses the unique ability to synthesise de
novo short RNA primers that are extended by the replicative
DNA polymerases on both strands of the unwound parental
DNA1, 2. The strict requirement for an oligonucleotide primer by
DNA polymerases has meant that primases are widespread in all
kingdoms of life. Because of the antiparallel nature of the DNA
double helix and the obligate 5′-to-3′ direction of nucleotide
polymerisation by DNA polymerases, priming events must take
place at frequent and regular intervals during lagging-strand
synthesis. In practice, leading-strand synthesis might also need
re-priming due to occasional interruptions caused by damaged or
blocked template. Thus, primase is a core component of the
multi-protein assembly known as the replisome that performs
DNA synthesis in all organisms3.
Primases synthesise short RNA oligonucleotides ranging in size
between 8 and 12 nucleotides. Primer synthesis comprises the
rate-limiting step of initiation, when the initial di-nucleotide
linkage is formed, followed by elongation and active termination4.
After extension by the replicative DNA polymerase, the RNA
primer is removed prior to ligation of the Okazaki fragments5. In
bacteria, primase is a single-chain multi-domain polymerase
known as DnaG, which interacts directly with the DnaB helicase
at the fork to prime DNA synthesis6. In archaea and eukarya,
primase is a constitutive heterodimer of a catalytic subunit, PriS
or Pri1, and a regulatory subunit, PriL or Pri27. In eukaryotic
replication, primase activity is tightly coupled to that of DNA
polymerase α (Pol α), to which it is constitutively bound in a
heterotetrameric assembly, the Pol α/primase complex8. After
completion of RNA primer synthesis, Pol α’s catalytic subunit
performs a limited primer extension with deoxynucleotides to
generate an RNA-DNA oligonucleotide that is elongated by Pol δ
and Pol ε on the lagging and leading-strand templates,
respectively9.
We now have a detailed structural knowledge of both primase
subunits, from crystallographic studies of archaeal and eukaryotic
primases10–13. PriS adopts a single-domain fold, which is con-
siderably simpler than that of other eukaryotic DNA and RNA
polymerases, and is also found in prokaryotic multi-functional
polymerases that perform DNA end-joining repair and in
plasmid-encoded primases14, 15. More recently, the PriS fold was
identiﬁed in PrimPol, a single-subunit enzyme that shares with
primase the ability of priming DNA synthesis and has a func-
tional role as translesion polymerase during replicative stress16–
18. In the PriS fold, the active site is located within an exposed
groove in the concave side of two divergent β-sheets, surrounded
on the outside by α-helices10, 12, 13, 19. PriL in contrast is entirely
α-helical, and docks on one side of PriS, providing it with a
protruding arm at the end of which is located its most conserved
region, an autonomously folded domain termed PriL-CTD11–13.
Although the mechanistic details of PriL’s involvement in
primase activity has remained obscure for a long time, eukaryotic
PriL is known to be important for primer synthesis20–22, and its
C-terminal domain contains amino acids that are essential for
primase activity20. Later studies demonstrated that the PriL of
archaeal and eukaryotic primases contain an Fe–S cluster within
its C-terminal domain, that the integrity of the PriL-CTD is
important for primer synthesis and that the PriL-CTD structure
bears remarkable similarity to the active-site region of DNA
photolyases, hinting at its evolutionary origin as an ancient
single-stranded (ss) DNA-binding module23–25. More recently,
the structure of the human PriL-CTD bound to an RNA/DNA
helix has provided a structural basis for the engagement of PriL
with the RNA primer during primer synthesis and for the speciﬁc
recognition of the triphosphate at the 5′-end of the RNA
primer26. Unexpectedly, a recent report has revealed that the
primase of the hyperthermophilic archaeon Sulfolobus solfataricus
contains a third subunit, named PriX27. This archaea-speciﬁc
subunit is structurally related to the most conserved part of the
eukaryotic PriL-CTD27. PriX is required for primase activity and
the protein is encoded by a gene that is essential for viability27.
Together, these biochemical and structural ﬁndings converge
towards a model of primer synthesis in which the critical step of
di-nucleotide formation requires the juxtaposition of the
nucleotide triphosphate (NTP) bound in the active site of PriS
(the elongation site) with a second NTP bound within the PriL-
CTD (the initiation site)7, 12, the latter nucleotide eventually
occupying the 5′-end position in the primer. Although the
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Fig. 1 Crystal structure of the heterotrimeric primase PriSLX from S.
solfataricus. a Two views of the PriSLX structure. The three subunits are
drawn as ribbons, colored blue (PriS), light blue (PriL) and purple (PriX).
The position and extent of the PriL-CTD is highlighted by a dashed oval.
The N- and C-terminal residues included in the crystallographic model are
labeled with N and C, respectively. The known location of the PriS active
site is indicated by a star. b View of the PriSLX structure that highlights the
mode of PriX binding to the PriSL subunits. PriX is shown as a purple ribbon,
as in panel A, whereas the PriS and PriL subunits are drawn as a solvent-
accessible gray molecular surface. The interface regions of PriS and PriL
that are within 5 Å of PriX are colored red
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architecture of the elongation site in PriS is now well-
characterised12, 28, the structural basis for PriL’s involvement in
primer synthesis, via NTP binding and possible functional role of
its Fe–S cluster, remains uncertain. Furthermore, the presence of
a Fe–S cluster cofactor has raised the important question of
whether its redox state plays a functional role in primase activ-
ity29. Here we provide evidence that addresses these two impor-
tant questions in primase activity, by identifying the initiation site
in the S. solfataricus PriSLX primase and demonstrating that its
Fe–S cluster is dispensable for primer synthesis.
Results
Crystal structure of PriSLX. To determine a structural basis for
the role of PriX in priming DNA synthesis during DNA repli-
cation, we determined the X-ray crystal structure of hetero-
trimeric PriSLX from S. solfataricus at 2.9 Å resolution (Fig. 1a
and Table 1). In the structure, the PriSL subunits adopt an
identical reciprocal arrangement as observed previously in the
crystal structure of the truncated PriSL11. The PriSLX structure
reveals that the six-helix bundle of globular PriX is docked within
the concave arch formed by PriS and PriL, and is coplanar with
them. The amino-terminal tail of PriX, which was disordered in
the crystal structure of the isolated protein27, extends away from
its helical core and reaches the carboxy-terminal domain of PriL
(PriL-CTD). The PriL-CTD appears to be only loosely connected
to the rest of PriL and is partially disordered, in agreement with
previous structural data for human primase13.
Because of its position near the PriS-PriL interface, PriX makes
contacts with both PriS and PriL subunits (Fig. 1b). The extent of
the binary interfaces as seen in the crystal structure is modest
(430 Å2 with PriS and 660 Å2 with PriL). We note that the
interaction between PriX and PriL is likely to be more extensive
than what observed in our crystallographic model, as biochemical
pull-down experiments show that the ﬁrst 27 amino acids of PriX
support binding to PriL-CTD, and that the minimal binding
region spans PriX amino acids 10 to 27 (Supplementary Fig. 1). In
the structure, the ﬁrst PriX amino acid that could be modeled in
the density map is P48; the PriX region spanning residues 48 to
56 sits in extended conformation in the groove formed by the
PriL-CTD and the rest of PriL’s larger helical structure. Our
inability to observe a larger portion of the PriL-bound PriX region
in the density map is likely due to the loose connection of PriL-
CTD with the rest of primase, as mentioned previously. Thus, the
interaction of the N-terminal tail of PriX with the PriL-CTD is
the critical contact that keeps PriX anchored to PriSL, which is in
agreement with previous observations27, and the additional
contacts with PriS and PriL are likely to be important for the
correct positioning of PriX relative to the rest of primase.
A nucleotide-binding site in PriX. PriSLX was crystallized in the
presence of RNA/DNA and the non-hydrolysable nucleotide
analog AMPCPP. Although no RNA/DNA was detected in the
density map, two AMPCPP molecules were clearly visible. The
ﬁrst AMPCPP was bound in the active site of PriS, in what is
considered the elongation site of primase12 (Supplementary
Fig. 2A). The nucleotide is bound in the same position and
orientation as observed for human and yeast primase12, 28. The
2′-hydroxyl group of the ribose in the bound AMPCPP makes
two hydrogen bonds to the main-chain carbonyl and nitrogen
moieties of PriS L245 and R247, respectively (Supplementary
Fig. 2B). A similar set of contacts with the 2′-hydroxyl of the
ribose were observed in the structure of human PriS bound to
UTP12 and might help explain the preference of primase for ribo-
over deoxy-ribonucleotide polymerisation.
Interestingly, the second AMPCPP located in the density map
was bound to PriX, at the edge of the PriX-PriS interface (Fig. 2
and Supplementary Fig. 3). The AMPCPP-binding site of PriX is
formed by the N-terminal turn of its second α-helix, at the center
of its globular fold, which grips the triphosphate moiety of the
AMPCPP in a manner reminiscent of the phosphate-binding loop
(P-loop or Walker A motif) of ATP- and GTP-binding proteins30.
The ribose of protein-bound AMPCPP remains exposed to
solvent, whereas the adenine base becomes sandwiched between
PriX and PriS. Lack of speciﬁc ribose recognition suggests that
PriX binding does not discriminate between NTP and dNTP. The
side chains of the basic 72-RKR-74 motif in PriX contact the
triphosphate, with R72 and R74 buttressed by supporting
interactions provided by Y103 and D140, respectively (Fig. 2b).
In addition, D70 binds to the triphosphate moiety via the shared
coordination of a Mn2+ ion.
Table 1 Data collection and reﬁnement statistics
PriSLX Chimera
Data collection
Wavelength (Å) 0.97625 0.97949
Resolution range (Å) 46.91–2.906
(3.01–2.906)
46.17–3.005
(3.113–3.005)
Space group P 41 C 1 2 1
Unit cell 104.9 Å 104.9 Å
229.8 Å 90 90 90
205.1 Å 36.3 Å 110.9 Å
90 96.907 90
Total reﬂections 504421 (48565) 53604 (5064)
Unique reﬂections 54380 (5392) 16582 (1556)
Multiplicity 9.3 (9.0) 3.2 (3.3)
Completeness (%) 99.96 (99.93) 98.63 (95.17)
Mean I/sigma(I) 15.09 (1.47) 9.18 (1.86)
Wilson B-factor 89.45 77.00
R-merge 0.105 (1.404) 0.1168 (0.8095)
R-meas 0.1112 (1.489) 0.1402 (0.9655)
R-pim 0.03641 (0.4952) 0.07654 (0.5204)
CC1/2 0.998 (0.527) 0.99 (0.535)
Reﬁnement
Reﬂections used in
reﬁnement
54374 (5392) 16579 (1556)
Reﬂections used for
R-free
2677 (271) 828 (75)
R-work 0.2283 (0.3081) 0.2412 (0.3726)
R-free 0.2713 (0.3434) 0.2980 (0.3845)
CC(work) 0.867 (0.686) 0.929 (0.582)
CC(free) 0.919 (0.582) 0.924 (0.432)
Number of non-
hydrogen atoms
11542 5117
Macromolecules 11412 5109
Ligands 130 1
Solvent 7
Protein residues 1405 625
RMS(bonds) 0.002 0.001
RMS(angles) 0.54 0.38
Ramachandran
favored (%)
93.47 93.85
Ramachandran
allowed (%)
6.09 5.50
Ramachandran
outliers (%)
0.44 0.65
Rotamer outliers (%) 3.29 3.68
Clashscore 6.57 4.36
Average B-factor 101.48 70.23
Macromolecules 101.53 70.26
Ligands 97.02 65.74
Solvent 51.67
Statistics for the highest-resolution shell are shown in parentheses
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The observation of a PriX-bound AMPCPP in the crystal
structure of PriSLX suggests the presence of a functional
nucleotide-binding site in PriX. Multiple sequence alignment of
PriX sequences shows that D70, R72 and R74 are invariant
residues (Supplementary Fig. 4A), as would be expected for
amino acids with an essential functional role in primase activity.
Intriguingly, superposition of PriX with eukaryotic PriL-CTD,
based on their known three-dimensional similarity27, shows that
structurally equivalent amino acids R355 of yeast PriL and R306
of human PriL superimpose with PriX R72 (Fig. 2b and
Supplementary Fig. 4B). Importantly, human R306 and yeast
R355 in PriL have been shown to be essential for the initiation
step of primer synthesis12, 20, 23. Our observation indicates that
these PriL residues could contribute to an analogous NTP-
binding site in the eukaryotic PriL-CTD, thus potentially
explaining their role in primase activity.
To test a possible role of the NTP-binding site in PriX, we
designed three single-point alanine mutants in PriX: D70, R72,
R74 (Fig. 2b), and analyzed their enzymatic activity in primer
synthesis assays (Fig. 3a, b), using a range of conditions, including
different template DNA sequences, primase concentrations, and
reaction conditions. Priming reactions on poly(dT) ssDNA
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Fig. 2 The nucleotide-binding site in PriX. a View of the PriSLX structure, highlighting the position of the two bound AMPCPP molecules. The primase
structure is drawn as in Fig. 1a, the AMPCPP is shown in stick representation. b Close-up view of the NTP-binding site of PriX with bound AMPCPP. The
side chains of the amino acids that form the NTP-binding site are shown. Polar contacts between side chains of NTP-binding residues and AMPCPP are
drawn as dashed lines, together with their distances in Ångström. The top-right inset shows a superposition of the yeast (green; PDB ID 3LGB) and human
(pink; PDB ID 3Q36) PriL-CTD structures. The side chain of arginine residues R355 (yeast) and R306 (human), that are essential for initiation of primer
synthesis, are also shown. The AMPCPP molecule of superimposed PriX (protein not shown) is overlaid on the PriL-CTD structures, to highlight its
proximity to R355 and R306
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showed no activity for any the mutants (Fig. 3a); on a mixed-
sequence DNA template, R72A mutant showed no activity,
whereas D70A and R74 mutants yielded some primer products
after prolonged incubation (Fig. 3b). As a control, alanine
mutation of PriL R232, which is close to R306 and R355 of
human and yeast PriL, based on sequence conservation of
archaeal/eukaryotic primases23, had no impact on primase
activity. Furthermore, measuring ﬂuorescein-ATP binding to
isolated PriX using ﬂuorescence polarisation showed that PriX
binds ATP with sub-micromolar afﬁnity and that the R72A
mutation abolishes binding (Fig. 3c). Together, these results
indicate that conserved PriX amino acids that bind to AMPCPP
in the crystal structure of PriSLX are essential for primer
synthesis, thus identifying the NTP-binding site in PriX as the
initiation site of primase.
Functional replacement of PriL-CTD by PriX in primer
synthesis. The identiﬁcation of an NTP-binding site in PriX that
is important for primer synthesis by archaeal primase suggested a
functional replacement of the PriL-CTD, which is essential for
initiation of primer synthesis in the eukaryotic primase, by PriX.
To test this hypothesis, we designed and prepared a heterodimeric
version of the S. solfataricus primase (named Chimera), which
contained wild-type PriS and a second subunit where amino acids
1 to 211 of PriL were fused to amino acids 42 to 154 of PriX, thus
excluding the PriL-CTD (Fig. 4a). Strikingly, Chimera was fully
active in primer synthesis assays on both poly(dT) and mixed-
sequence DNA templates, in support of the hypothesis that PriX
had replaced PriL-CTD as the functional module that cooperates
with PriS in S. solfataricus primase (Fig. 4b, c). Taken together,
these results show that PriX is necessary and sufﬁcient to endow
primase with the ability to initiate RNA primer synthesis.
To analyze further the biochemical properties of Chimera and
of PriSLX bearing single-point PriX mutations D70A, R72A and
R74A, we analyzed their ability to support DNA synthesis using a
primase-dependent reconstituted DNA replication assay with
puriﬁed S. solfataricus protein components and an M13 ssDNA
template (Supplementary Fig. 5). The experiments showed that
Chimera was able to prime levels of DNA synthesis that were
comparable to those of wild-type PriSLX (Fig. 5), thus conﬁrming
the results of the primase assay (Fig. 4). Furthermore, the R72A
and R74A mutants showed barely detectable and greatly
diminished levels of DNA synthesis, respectively; the D70A
mutant also showed clearly reduced DNA synthesis.
PriX is required for the initiation of primer synthesis. To
investigate further the functional role played by PriX in primase
activity, we examined the nature of the impairment in primer
synthesis caused by the PriX mutants D70A, R72A and R74A.
Primer synthesis on poly(dT) using 32P-αATP showed that the
defect of the PriX mutants was speciﬁc to the initiation step, as
clearly detectable extension products were observed when an
oligo(A8) primer was provided in the reaction (Fig. 6a). To be
able to compare the ability of the PriX mutants to extend an
existing primer relative to the wild-type primase, the extension
assay was repeated using 32P-labeled oligo(A8). The results of the
experiment showed that PriX mutants had comparable levels of
activity to wild-type primase, and that both PriX mutants and
Chimera were able to synthesise longer extension products
(Fig. 6b).
These data proved that, when presented with both a DNA
template and an RNA primer, the defect in NTP binding by PriX
did not affect the ability of primase to function as DNA-
dependent RNA polymerase. Thus, PriX has a speciﬁc, essential
role in the initiation step of primer synthesis. As formation of the
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Fig. 3 PriX NTP-binding residues are necessary for RNA primer synthesis. a
Primer synthesis assay on poly(dT) ssDNA for increasing concentrations
(125 nM, 250 nM and 500 nM) of wild-type and mutant PriSLX. The
reaction products were separated by PAGE under denaturing conditions
and detected by phosphorimaging of the incorporated 32P-αATP. b Primer
synthesis assay on mixed-sequence ssDNA 100mer with ﬁxed
concentration of wild-type and mutant primase, at 10′ and 40′ time points.
The reaction products were separated by denaturing PAGE, stained with
SYBR Gold and detected by phosphorimaging. c ATP binding by wild-type
and R72A PriX. Binding was measured by ﬂuorescence polarization of
ﬂuorescein-labeled ATP in the presence of increasing amounts of primase
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ﬁrst phosphodiester bond between two nucleotides is the critical
catalytic step in the initiation step of primer synthesis, we sought
to determine whether provision of the ribo-di-nucleotide ApA
would sufﬁce to compensate for the initiation defect of the PriX
mutants. Indeed, the PriX mutants were able to extend the ApA
dinucleotide, albeit by a single nucleotide (Fig. 6c). The reason for
the limited extension might be the inefﬁcient interaction of
primase with such as short primer, when operating in polymerase
mode.
The crystal structure of PriSLX is active in primer elongation.
The position of PriX and its bound nucleotide relative to the PriS
active site is not immediately suggestive of a possible mechanism
explaining PriX involvement in primer synthesis. We set out to
ascertain in the ﬁrst instance whether the relative arrangement of
primase subunits observed in the crystal structure of PriSLX is
present in solution. To this purpose, we adopted a structure-
guided site-speciﬁc cross-linking approach: we chose pairs of
residues that are present at the PriS–PriX interface in the PriSLX
crystal structure (Fig. 7a), and selected them for cysteine muta-
genesis. The primase containing the two cysteine mutations was
then subjected to cross-linking using the cross-linker bis-mal-
eimidoethane (BMOE), and the pattern of cross-linked primase
subunits was analyzed by SDS-PAGE.
The results of the cross-linking analysis for the amino acid pair
PriS E34 and PriX K110, as well as for control primase mutants
containing either PriS T11C, PriS E34C or PriS T11C, PriX
K110C mutations, where T11 is located in the disordered N-tail
of PriS, are reported in Fig. 7b. Whereas the wild-type PriSLX was
not affected by the presence of BMOE, and the control
experiment showed a ladder of products indicative of non-
speciﬁc cross-linking, the PriS E34C, PriX K110C double mutant
primase showed clearly a predominant product corresponding to
cross-linked PriS and PriX. This result indicates that the
crystallographic model determined for the PriSLX crystals does
exist and it is prevalent in solution. The cross-linking experiment
was performed for both PriSLX and Chimera, yielding equivalent
results, in further support of Chimera’s recapitulation of the
behavior of wild-type PriSLX.
Interestingly, when the cross-linking was repeated with
primase bound to an RNA/DNA molecule, a different result
was obtained according to whether the RNA contained a
triphosphate group on its 5′-nucleotide (5′-pppRNA) (Supple-
mentary Fig. 6). Thus, whereas addition of RNA/DNA to the
reaction did not change the amount of cross-linked PriS-PriX
subunits, the presence of 5′-pppRNA/DNA reduced noticeably
the amount of cross-linked material. These results can be
interpreted to indicate that engagement with the templated 5′-
pppRNA caused a rearrangement in primase structure, away from
the conformation observed in the PriSLX crystals.
Having ascertained that the primase structure of the PriSLX
crystals does exist in solution, we aimed to determine whether it is
functional in primer synthesis. In order to do this, primase assays
were performed with a PriS E34C, PriX K110C double mutant
that had been cross-linked and puriﬁed by gel-ﬁltration
chromatography (Supplementary Fig. 7). As it proved to be
easier to cross-link the Chimera double mutant to completion, it
was used in the primase assays. Primer initiation assay showed no
primer synthesis by the cross-linked Chimera (Fig. 8a), in support
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Fig. 4 Design and functional characterization of Chimera. a Subunit structure of wild-type PriSLX and Chimera. In the second subunit of Chimera, amino
acids 1 to 211 of PriL are fused to amino acids 42 to 154 of PriX. b Primer synthesis assay on mixed-sequence ssDNA 30mer with ﬁxed concentration of
wild-type and mutant primase, at 10′, 20′ and 40′ time points. The reaction products were separated by denaturing PAGE, stained with SYBR Gold and
detected by phosphorimaging. c Primer synthesis assay on poly(dT) ssDNA with increasing concentrations (125 nM, 250 nM, and 500 nM) of wild-type
PriSLX and Chimera. The reaction products were separated by PAGE under denaturing conditions and detected by phosphorimaging of the incorporated
32P-αATP
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of the view that the PriSLX conformation, as seen in the crystal
structure, is not compatible with primer initiation. However,
RNA primer extension assays using either NTP (Fig. 8b) or dNTP
(Fig. 8c) did show primer elongation, indicating that the crystal
structure of PriSLX represents a biochemically active and
potentially physiologically relevant conformation.
Discussion
Here we have presented the crystal structure of the heterotrimeric
PriSLX primase from S. solfataricus and have clariﬁed the role of
its novel PriX subunit in RNA primer synthesis. We have shown
that PriX has replaced the Fe–S cluster domain of PriL as the
primase module responsible for endowing primase with the
ability to initiate nucleic acid synthesis. We have further shown
that the critical role of PriX in primer initiation stems from its
ability to bind NTPs and have identiﬁed the amino acids
involved.
The nucleotide-binding site of PriX bears resemblance to the
phosphate-binding loop (P-loop or Walker A motif) of ATP- and
GTP-binding proteins. The β- and γ-phosphates of the bound
nucleotide are nested within the N-terminal turn of the central α-
helix in the PriX globular fold, and make hydrogen bonds with
the main-chain nitrogens of the 72-RKR-74 motif. Furthermore,
the three phosphates are bound to a Mn2+ ion, with D70, pro-
viding an additional point of coordination. Alanine mutation of
D70, R72, R74 abolish or severely impair the initiation step of
primer synthesis, but leave unaffected the ability of primase to
extend an existing primer, indicating that the NTP-binding site in
PriX represents the initiation site of primase.
The presence of a novel NTP-binding site in PriX, distinct
from the elongation site in PriS, provides support to the model
that archaeal/eukaryotic primases possess two independent NTP-
binding sites, the elongation and initiation sites, that must
become transiently juxtaposed to promote synthesis of the ﬁrst
di-nucleotide in the RNA primer (Fig. 9). The conformation
change required to juxtapose the ﬁrst two nucleotides highlights a
distinctive mechanism of initial dinucleotide synthesis for pri-
mase. We speculate that the initiation-competent conformation
of primase may align the ﬁrst two nucleotides for phosphodiester
bond formation in a manner similar to that suggested for Prim-
Pol18. The proposed primase initiation mechanism is different
from the initiation mechanism employed by transcription RNA
polymerases, where the active site is buried deep within the multi-
subunit enzyme and can accommodate two NTPs during tran-
scription initiation31. The structural basis for the conformational
rearrangements that allow archaeal and eukaryotic primases to
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achieve the initiation state competent for di-nucleotide synthesis
remains currently unknown.
The identiﬁcation of a second NTP-binding site in primase was
made during attempts to co-crystallize primase with RNA/DNA
and a non-hydrolysable nucleotide analog, AMPCPP. The con-
formation of PriSLX observed in the crystals appears to be pre-
dominant in solution, as judged by the cross-linking experiments
of Fig. 7b, and it is a conformation that is also adopted by the
Chimera. The ability of the cross-linked Chimera to extend an
existing primer, when constrained in a similar conformation to
the PriSLX crystal structure, argues that, in addition to existing in
solution, the conformation is physiologically relevant. The fact
that the cross-linked Chimera was exclusively active in the
extension, but not initiation, of an RNA primer, points to the
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conformation of the crystal structure as representing a ‘poly-
merase’ mode. From these observations, it follows that PriX must
transition between different conformational states to be able to
initiate primer synthesis. Interestingly, the crystal structure of
Chimera shows that covalently-linked PriX occupies a similar but
not identical position relative to PriX in the PriSLX structure,
possibly representing an intermediate point in a putative PriX
trajectory between initiation and extension states (Supplementary
Fig. 8).
Previous studies had shown that the PriL subunit provides the
eukaryotic primase with the ability to initiate primer synthesis, by
means of a conserved C-terminal Fe–S cluster domain, the PriL-
CTD23. A surprising implication of our ﬁndings is that PriX has
replaced PriL as the primase subunit that provides this essential
initiation ability in the archaeal primase of S. solfataricus (Fig. 9).
Thus, our work extends signiﬁcantly the earlier demonstration of
structural similarity between archaeal PriX and eukaryotic PriL-
CTD27, by showing that the similarity includes their functional
roles. We prove this point beyond doubt, by demonstrating that
an engineered version of PriSLX, lacking the PriL-CTD retains
priming activity.
Furthermore, our ﬁndings have important implications for the
debated role of the Fe–S cluster in primer synthesis. Recent
reports had suggested that the redox activity of the Fe–S cluster of
primase is important for primer synthesis, by regulating the
DNA-binding afﬁnity of primase29. Our evidence of a functional
replacement of PriL-CTD by PriX indicates that neither the
presence of a Fe–S cluster nor, therefore, its putative redox
activity are required for primer synthesis in the archaeal primase
of S. solfataricus. While it remains possible that eukaryotic pri-
mases might operate via a different mechanism of primer
synthesis, their close structural and functional relationship with
archaeal primases makes it unlikely that the Fe–S cluster would
have a redox function in the priming reaction of the eukaryotic
enzyme.
Methods
Expression and puriﬁcation of PriSLX and Chimera. A pETDuet vector
expressing PriL, PriS and a pRSFDuet vector expressing PriX were co-transformed
into Rosetta2(DE3) cells (Novagen). The resulting colonies were used to inoculate
Turbo Broth™ (Molecular Dimensions) media supplemented with 35 μg ml−1
kanamycin, 35 μg ml−1 chloramphenicol, 100 μg ml−1 ampicillin. The culture was
grown to an OD600 of 1.0 at 37 °C and constant shaking at 200 r.p.m., induced with
1 mM IPTG and incubated at 37 °C and constant shaking for 3 h. The bacteria were
collected by centrifugation and the pellets were resuspended in 15 mL of lysis buffer
(25 mM Hepes pH 7.2, 150 mM NaCl, 5 mM DTT, EDTA-free protease inhibitor
cocktail tablets (Sigma) and 25 units of benzonase (Millipore) per liter of cell
culture. The cells were lysed by sonication (Sonics Vibra-Cell™; 5 s pulse and 10 s
off, 60% amplitude, 3.5 min). The cell lysate was split into 25 mL aliquots, trans-
ferred into 50 mL falcon tubes and incubated in a 70 °C water bath for 20 min.
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After heat denaturation, the cell suspension was centrifuged at 18,000×g for 1 h.
The supernatant was ﬁltered through a 5.0 μm syringe ﬁlter and the ﬁltrate loaded
onto a 5 mL Heparin HP column (GE Healthcare). The Heparin column was
connected to an ÄKTA puriﬁer system (GE Healthcare) and the protein eluted with
a 10-column volume gradient from 150 to 1000 mM NaCl in the presence of 25
mM Hepes 7.2. The pooled fractions were concentrated, loaded onto a Superdex
200™ 16/600 size-exclusion chromatography column (GE Healthcare) and eluted in
a 25 mM Hepes pH 7.2 and 150 mM NaCl buffer. Peak fractions corresponding to
puriﬁed PriSLX were pooled, concentrated and kept in aliquots at −80 °C.
To prepare the Chimera construct, we generated by overlap extension PCR an
open-reading frame encoding PriX amino acids 41–154 fused to amino acids 1–211
of PriL, resulting in a PriLX protein lacking the C-terminal domain of PriL
(residues 212–307). The construct was cloned into the pETDuet PriSL vector,
replacing PriL, for co-expression with the pRSFDuet vector expressing PriX. The
resulting PriSLX protein (Chimera) was expressed and puriﬁed following the same
protocol as wild-type PriSLX.
Expression and puriﬁcation of S. solfataricus proteins. Proteins were expressed
and puriﬁed essentially as previously described: PCNA32, RFC29, PolB1-HE30,
SSB33. S. solfataricus MCM, GINS and Cdc45 were expressed and puriﬁed fol-
lowing the scheme described in Xu et al34.
Crystallization and structure determination of PriSLX. PriSLX was crystallized
using vapour diffusion in sitting drops at 19 °C, by mixing 200 nL of PriSLX sample
with 100 nL of reservoir solution with the mosquito robot (TTP Labtech) in MRC 2
Well sitting drop crystallization plates. The PriSLX sample contained 25 mM Hepes
pH 7.2, 150 mM NaCl, 1 mM TCEP, 1 mM MnCl2, 2 mM AMPCPP, 100 μM
PriSLX and 120 μM of the RNA-DNA hybrid sequence 5′-(TTCGATCAGG-
TAGC)DNA(UUUGCUACCUGAUCG)RNA-3′. The reservoir solution contained
11% PEG 8000, 21.5% ethylene glycol, 0.1 M bicine/Trizma base pH 8.5, 0.03 M di-,
tri-, tetra- and penta-ethyleneglycol (Morpheus crystallization screen, Molecular
Dimensions). The crystals were improved by streak seeding into the initial crys-
tallization conditions, and cryoprotected before freezing in liquid nitrogen by
addition of reservoir solution to the crystal drop.
X-ray diffraction data of the PriSLX crystals were collected at the I03 beam line
of the Diamond Synchrotron Light Source. 1200 frames were collected with an
oscillation range of 0.2 degrees and at a wavelength of 0.97625 Å. The data set was
indexed in P41 with unit cell dimensions 104.9 Å, 104.9 Å, 229.8 Å, 90.0°, 90.0°,
90.0°, scaled and integrated with the XDS software package35. The structure was
solved by Molecular Replacement with Phaser as implemented in Phenix, using the
heterodimeric structure of the core primase as input model (PDB ID: 1ZT2)11, 36, 37.
The quality of the resulting electron density map was improved with Phenix Reﬁne
and the available PriX structure (PDB ID: 4WYH) was manually ﬁtted into the
density map using Coot27, 36, 38. Subsequently, the structure, containing two copies
of the PriSLX heterotrimer in the asymmetric unit, was completed with iterative
cycles of manual structure building in Coot and reﬁnements in Phenix-Reﬁne to 2.9
Å. The ﬁgures used to present the crystal structure were generated with Chimera39.
Crystallization and structure determination of Chimera. The Chimera was
crystallized by vapour diffusion at 19 °C. 2 μL of protein solution was mixed with 2
μL of reservoir solution in a 6 well hanging-drop crystallization plate containing 1
mL reservoir solution. The protein was at 60 μM concentration in 25 mM Hepes
pH 7.2, 150 mM NaCl, 1 mM TCEP. The reservoir solution consisted of 12% PEG
3350, 200 mM CaCl2, 0.5% n-octyl-β-D-glucoside. For cryo-protection, the mother
liquor was replaced by 4 consecutive exchanges of 2 μL cryo-solution (10%
PEG3350, 100 mM CaCl2, 100 mM NaCl, 25 mM Hepes pH 7.2, 25% ethylene
glycol, 1 mM TCEP). After the buffer exchanges, the crystals were mounted onto
nylon loops and frozen in liquid nitrogen.
The X-ray diffraction data were collected at the I02 beam line of the Diamond
Synchrotron Light Source. The wavelength was set to 0.97949 Å and 1800 frames
were collected with an oscillation range of 0.1 degrees. The data set was processed
in the space group C2, with unit cell dimensions 205.1 Å, 36.3 Å, 110.9 Å, 90°,
96.9°, 90° and one copy of Chimera in the asynmmetric unit, using XDS35. The
phases were obtained by molecular replacement using Phaser37 and the
heterodimeric structure of the core primase as input model (PDB ID: 1ZT2). The
structure was reﬁned to 3.0 Å with iterative cycles of manual structure building in
Coot38 and reﬁnements in PhenixReﬁne36.
Pull-down experiments. The ﬂag-tagged PriX N-terminal constructs were co-
expressed with His-Sumo tagged PriLCTD from a pRSF-Duet vector in Rosetta2
DE3 cells (Novagen). Colonies were inoculated into 10 mL of Turbo Broth™
(Molecular Dimensions) with 35 μg mL−1 kanamycin and 35 μg ml−1 chlor-
amphenicol in 50 mL conical tubes and the cultures grown with shaking to an
OD600 of 1.0, when the temperature was reduced to 20 °C and the cultures induced
with 0.3 mM IPTG. After 16 h, the cells were collected by centrifugation at 4000×g
for 10 min. 2 mL of 150 mM NaCl, 25 mM Hepes pH 7.2 supplemented with
EDTA-free protease inhibitor cocktail tablets and 10 units benzonase was used to
resuspend the cell pellets. The cell suspension was transferred into 2 mL tubes and
the cells lysed by sonication (30 s, 10 s on and 10 s off, 60% amplitude). The lysate
was centrifuged at 4 °C at 17′000×g for 30 min. Subsequently, the lysate was applied
onto 40 μL anti-FLAG M2 beads (Sigma-Aldrich) and incubated on a roller-shaker
at 4 °C for 1 h. Using a magnetic rack the beads were washed with 3 × 1mL of 150
mM NaCl, 25 mM Hepes pH 7.2. Finally the protein was incubated for 30 min on
ice with 40 μL wash buffer supplemented with 300 μg mL−1 triple-FLAG peptide
(Sigma-Aldrich) for elution. The eluted samples were mixed with loading buffer
and analyzed by SDS-PAGE.
Mixed-sequence primase activity assays. The assay reactions were set up by
mixing 0.5 μM primase, 0.5 μM template oligonucleotide (for initiation: DNA
template 5′-GTTGTCCATTATGTCCTACCTCGTGCTCCT-3′; for extension:
DNA template 5′-TTTTTTTTTTTTTTTTTTTTCCAGAGAGCGCCCAAACG-3′
and RNA primer 5′-GGUCUCUCGCGGGUUUGC-3′), 1 mM NTP (or dNTP) in
the assay buffer: 25 mM Hepes pH 7.2, 100–150 mM NaCl, 5 mM MgCl2 (or
MnCl2), 1 mM TCEP. The reactions were incubated in a PCR thermocycler at
60 °C. For each time point, a separate reaction was run and stopped after 10, 20 or
40 min with a 1:1 ratio of reaction mixture to quenching buffer (95% formamide,
25 mM EDTA, xylene cyanole). The samples were then analyzed on denaturing
20% polyacrylamide-urea gel, by electrophoresis in 0.5× TBE buffer at 500 V for 90
min. For visualisation of RNA and DNA, the gel was stained in 0.5x TBE with 1/10′
000 SYBR Gold (ThermoFisher) for 20 min and imaged using a Typhoon FLA 9500
(GE Healtcare).
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Poly(dT)-templated primase assay. Ten-microlitre reactions contained 50 mM
MES-NaOH pH 6.5, 10 mMMnCl2, 0.1 mg ml−1 BSA, 10 μM ZnCl2, 10 μM ATP, 1
μCi [α-32P]ATP, 100 ng poly(dT) (Amersham biosciences), 150 μM ApA (TriLink
BioTechnologies, presented in ApA extension assay), 160 nM ribo(A8) (IDT,
presented in 8mer primer extension assay) and the indicated amount of primases.
The reactions were incubated at 75 °C for 20 min before being quenched by the
addition of an equal volume of loading buffer (98% formamide, 10 mM EDTA).
The mixtures were boiled for 5 min and analyzed by electrophoresis through a 20%
polyacrylamide, 8 M Urea, 1 × TBE gel and visualized by phosphorimagery on a
Typhoon scanner (GE Healthcare).
End-labeled primer extension assay. ApA or ribo(A8) was end labeled with [γ-
32P]ATP using T4 PNK (New England Biolabs) and labeled ribo(A8) primer was
annealed to poly(dT) prior to the reaction. The reaction condition is essentially the
same as the primase assay except containing 80 μM ATP and 32P 5′-end-labeled
ApA (50 nM) or ribo(A8) primed poly(dT) (33 nM). ApA and ribo(A8) primer
extension products were analyzed with 23% and 20% polyacrylamide gel,
respectively.
M13 DNA replication assay. Reactions were performed in a volume of 10
microlitres containing 50 mM Tris pH 6.0, 10 mM DTT, 0.1 mg ml−1 BSA, 10 mM
MgCl2, 200 μM each rCTP, rUTP, rGTP, 5 mM ATP, 60 μM of each dATP, dTTP,
dGTP, 20 μM dCTP, 2 μCi [α-32P]dCTP, 5 ng M13mp18 ssDNA (New England
Biolabs), 24 nM MCM, 140 nM Cdc45-GINS, 100 nM PCNA, 50 nM RFC, 50 nM
PolB1-HE, 400 nM SSB and 50 nM primase (unless otherwise indicated). The
reactions were incubated at 75 °C for 20 min before being quenched by the addition
of an equal volume of stop buffer (40 mM EDTA, 1% SDS) and 4 μl alkaline gel-
loading buffer (300 mM NaOH, 6 mM EDTA, 18% (w/v) Ficoll, 0.15% (w/v)
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bromocresol green, 0.25% (w/v) xylene cyanol). The products were analyzed by
electrophoresis through a 1% alkaline agarose gel and visualized using by phos-
phorimaging on a Typhoon scanner.
Fluorescence anisotropy. The nucleotide-binding afﬁnity of PriX was determined
by measuring ﬂuorescence polarization of ﬂuorescein-labeled ATP (Jena
Bioscience) in the presence of increasing amounts of PriX. The labeled ATP was
used at a constant concentration of 20 nM and mixed with a dilution series of PriX
ranging from 0 to 20–30 μM concentration, in 25 mM Hepes 7.2, 150 mM NaCl, 2
mM MnCl2, 1 mM TCEP buffer. A total of 90 μL of each sample was transferred
into 96-well NBS plates (Corning) and the polarization measured with a PHER-
Astar FS plate reader (BMG Labtech) using an excitation wavelength of 485 nm
and an emission wavelength of 520 nm at 25 °C.
Analytical BMOE cross-linking. A concentration of 2.2 mg of BMOE (Thermo
Fisher Scientiﬁc) were dissolved in 0.5 mL DMSO to obtain a 20 mM cross-linker
stock. A 200-fold dilution (0.1 mM) with reaction buffer (25 mM Hepes pH 7.2,
150 mM NaCl, 5 mM MnCl2) was prepared and 2 μL of it added to 17 μL of 5 μM
primase. Depending on the experiment, 10 μM of a DNA/RNA hybrid with or
without a 5′-triphosphate was added to the primase solution (5′-ppp-(GGCUC
GG)RNA-3′ and 5′-(AACACCGAGCCAACAT)DNA-3′). The cross-linking reaction
was incubated at 25 °C for 1 h. To quench the reaction, 1 μL of 1M DTT was added
to the reaction mixture and incubated for an additional 15 min. Finally, 10 μL of
SDS gel-loading buffer was added and 15 μL of the mixture loaded onto a SDS-
PAGE gel for analysis.
Preparative BMOE cross-linking. The individual and double PriS E34C and PriX
K110C mutants of Chimera were prepared as described above and adjusted to a
protein concentration of 20 μM. BMOE to a ﬁnal concentration of 40 μM was then
added to the protein sample and incubated for 30 min at 25 °C before the absolute
BMOE concentration in the reaction was increased to 80 μM and incubated for
further 30 min. Subsequently the reaction was stopped by adding a ﬁnal con-
centration of 5 mM DTT to the mixture followed by a 10 min incubation at 25 °C.
If necessary, the protein was concentrated with a spin concentrator to a volume of
1–2 mL and subjected to a Superdex S200 16/600 size-exclusion chromatography
column (GE Healthcare). The puriﬁed cross-linked protein was then used for gel-
based activity assay as described above.
Data availability. Coordinates and structure factors have been deposited in the
Protein Data Bank under accession codes 5OF3 (PriSLX) and 5OFN (Chimera).
The data that support the ﬁndings of this study are available from the corre-
sponding author upon request.
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